Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garvey

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 9, 2014
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 27, 2021
Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective studyC A McCormick, L Domegan, P G Carty, et al.
Renal Failure|May 8, 2010
Encapsulating peritoneal sclerosis: experience of a tertiary referral centerP J Phelan, J J Walshe, A Al-Aradi, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.
Journal of Virology|May 22, 2009
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivoChristine Goffinet, Ina Allespach, Lena Oberbremer, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 7, 2014
Outbreak of hepatitis A infection associated with the consumption of frozen berries, Ireland, 2013--linked to an international outbreakM Fitzgerald, L Thornton, J O'Gorman, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2017
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicansTimothy J Break, Jigar V Desai, Mukil Natarajan, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|June 9, 2014
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groupsBrian A Johns, Takashi Kawasuji, Jason G Weatherhead, et al.
Critical Care Medicine|May 20, 1998
Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in caninesB D Freeman, F Zeni, S M Banks, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|October 27, 2021
Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective studyC A McCormick, L Domegan, P G Carty, et al.
Renal Failure|May 8, 2010
Encapsulating peritoneal sclerosis: experience of a tertiary referral centerP J Phelan, J J Walshe, A Al-Aradi, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.
Journal of Virology|May 22, 2009
Pharmacovirological impact of an integrase inhibitor on human immunodeficiency virus type 1 cDNA species in vivoChristine Goffinet, Ina Allespach, Lena Oberbremer, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 7, 2014
Outbreak of hepatitis A infection associated with the consumption of frozen berries, Ireland, 2013--linked to an international outbreakM Fitzgerald, L Thornton, J O'Gorman, et al.
The Journal of Antimicrobial Chemotherapy|October 18, 2017
VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicansTimothy J Break, Jigar V Desai, Mukil Natarajan, et al.
Pageof 13